May maybes as Spanish in prepares to pay back d€bt €Billions to pharma
This article was originally published in Scrip
There is soon to be some relief for pharmaceutical companies in Spain that have been struggling to recover hospital debts related to drug purchases totalling €6.3 billion. A €35 billion "liquidity injection" from the central Spanish government should see regional and local authorities start to pay back providers, said the treasury this week. However, it is far from clear that the financial jab in the arm provides any comfort for the pharma industry beyond the immediate future.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.